• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Balancing risks and rewards: How hematologists discuss uncertainty in allogeneic hematopoietic cell transplantation outcomes.权衡风险与回报:血液学家如何讨论异基因造血细胞移植结果中的不确定性。
Patient Educ Couns. 2024 Jun;123:108177. doi: 10.1016/j.pec.2024.108177. Epub 2024 Feb 1.
2
Communication Strategies of Transplant Hematologists in High-Risk Decision-Making Conversations.移植血液学家在高风险决策对话中的沟通策略。
JCO Oncol Pract. 2024 Apr;20(4):538-548. doi: 10.1200/OP.23.00574. Epub 2024 Jan 19.
3
Process of allogeneic hematopoietic cell transplantation decision making for older adults.老年患者异基因造血细胞移植决策过程
Bone Marrow Transplant. 2016 May;51(5):623-8. doi: 10.1038/bmt.2015.241. Epub 2015 Oct 12.
4
Presalvage International Staging System Stage and Other Important Outcome Associations in CD34-Selected Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma.CD34 分选异基因造血干细胞移植治疗多发性骨髓瘤的保前国际分期系统分期和其他重要结局相关性。
Biol Blood Marrow Transplant. 2020 Jan;26(1):58-65. doi: 10.1016/j.bbmt.2019.08.023. Epub 2019 Sep 5.
5
Fertility preservation in patients with hematologic malignancies and recipients of hematopoietic cell transplants.血液系统恶性肿瘤患者和造血细胞移植受者的生育力保存。
Blood. 2019 Aug 29;134(9):746-760. doi: 10.1182/blood.2018846790. Epub 2019 Jul 10.
6
The role of hematopoietic cell transplantation in adult ALL: clinical equipoise persists.造血细胞移植在成人 ALL 中的作用:临床平衡仍然存在。
Leuk Res. 2014 Feb;38(2):176-9. doi: 10.1016/j.leukres.2013.10.021. Epub 2013 Nov 1.
7
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.异基因反应性作为血液系统恶性肿瘤治疗的治疗原则。非清髓性预处理的异基因造血细胞移植的临床和免疫学方面的研究。
Dan Med Bull. 2007 May;54(2):112-39.
8
Medical nutrition therapy during intensive remission-induction treatment and hematopoietic stem cell transplantation in acute myeloid leukemia patients: Hematologists' experiences and perspectives.急性髓系白血病患者强化缓解诱导治疗和造血干细胞移植期间的医学营养治疗:血液科医生的经验和观点。
Clin Nutr ESPEN. 2023 Oct;57:399-409. doi: 10.1016/j.clnesp.2023.07.015. Epub 2023 Jul 18.
9
Significant improvement in survival after allogeneic hematopoietic cell transplantation during a period of significantly increased use, older recipient age, and use of unrelated donors.在异体造血细胞移植使用率显著增加、受体年龄较大以及使用非亲缘供体的情况下,患者的生存率得到了显著提高。
J Clin Oncol. 2013 Jul 1;31(19):2437-49. doi: 10.1200/JCO.2012.46.6193. Epub 2013 May 28.
10
Multicenter biologic assignment trial comparing reduced-intensity allogeneic hematopoietic cell transplant to hypomethylating therapy or best supportive care in patients aged 50 to 75 with intermediate-2 and high-risk myelodysplastic syndrome: Blood and Marrow Transplant Clinical Trials Network #1102 study rationale, design, and methods.多中心生物制剂分配试验:比较降低强度的异基因造血细胞移植与低甲基化疗法或最佳支持治疗,用于年龄在50至75岁、患有中危2和高危骨髓增生异常综合征的患者:血液和骨髓移植临床试验网络#1102研究原理、设计和方法
Biol Blood Marrow Transplant. 2014 Oct;20(10):1566-72. doi: 10.1016/j.bbmt.2014.06.010. Epub 2014 Jun 24.

引用本文的文献

1
Racial Disparities in Doctor-Patient Communication: Examining Doctors' Encounters with Black and White Patients.医患沟通中的种族差异:审视医生与黑人和白人患者的交流。
J Racial Ethn Health Disparities. 2025 Mar 12. doi: 10.1007/s40615-025-02374-0.

本文引用的文献

1
Communication Strategies of Transplant Hematologists in High-Risk Decision-Making Conversations.移植血液学家在高风险决策对话中的沟通策略。
JCO Oncol Pract. 2024 Apr;20(4):538-548. doi: 10.1200/OP.23.00574. Epub 2024 Jan 19.
2
Navigating the perils and pitfalls throughout the consent process in hematopoietic cell transplantation.在造血细胞移植的整个同意过程中,要注意各种风险和陷阱。
Blood Rev. 2023 May;59:101037. doi: 10.1016/j.blre.2022.101037. Epub 2022 Dec 20.
3
Diagnosis and Treatment of Myelodysplastic Syndromes: A Review.骨髓增生异常综合征的诊断与治疗:综述
JAMA. 2022 Sep 6;328(9):872-880. doi: 10.1001/jama.2022.14578.
4
Patient and Provider Perspectives on the Impacts of Unpredictability for Patient Sensemaking: Implications for Intervention Design.患者与医疗服务提供者对不可预测性对患者意义构建的影响的看法:对干预设计的启示
J Patient Exp. 2022 Mar 29;9:23743735221089460. doi: 10.1177/23743735221089460. eCollection 2022.
5
Comparison Between 5-Azacytidine Treatment and Allogeneic Stem-Cell Transplantation in Elderly Patients With Advanced MDS According to Donor Availability (VidazaAllo Study).5-氮杂胞苷治疗与供者情况的异基因造血干细胞移植在老年进展性 MDS 患者中的比较(VidazaAllo 研究)。
J Clin Oncol. 2021 Oct 20;39(30):3318-3327. doi: 10.1200/JCO.20.02724. Epub 2021 Jul 20.
6
Biologic Assignment Trial of Reduced-Intensity Hematopoietic Cell Transplantation Based on Donor Availability in Patients 50-75 Years of Age With Advanced Myelodysplastic Syndrome.基于供者可用性的 50-75 岁中高危骨髓增生异常综合征患者减低强度异基因造血干细胞移植的生物学分配试验
J Clin Oncol. 2021 Oct 20;39(30):3328-3339. doi: 10.1200/JCO.20.03380. Epub 2021 Jun 9.
7
How Physicians Manage Medical Uncertainty: A Qualitative Study and Conceptual Taxonomy.医生如何应对医疗不确定性:一项定性研究和概念分类学。
Med Decis Making. 2021 Apr;41(3):275-291. doi: 10.1177/0272989X21992340. Epub 2021 Feb 15.
8
Stress and coping strategies among allogeneic haematopoietic stem cell transplantation survivors: A qualitative study.异基因造血干细胞移植存活者的压力和应对策略:一项定性研究。
Eur J Cancer Care (Engl). 2020 Nov;29(6):e13307. doi: 10.1111/ecc.13307. Epub 2020 Sep 5.
9
Communicating treatment risks and benefits to cancer patients: a systematic review of communication methods.向癌症患者传达治疗风险和获益:沟通方法的系统评价。
Qual Life Res. 2020 Jul;29(7):1747-1766. doi: 10.1007/s11136-020-02503-8. Epub 2020 Apr 24.
10
Illness and prognostic understanding in patients with hematologic malignancies.血液病恶性肿瘤患者的疾病和预后认知。
Blood Rev. 2021 Jan;45:100692. doi: 10.1016/j.blre.2020.100692. Epub 2020 Apr 6.

权衡风险与回报:血液学家如何讨论异基因造血细胞移植结果中的不确定性。

Balancing risks and rewards: How hematologists discuss uncertainty in allogeneic hematopoietic cell transplantation outcomes.

机构信息

University of Wisconsin Carbone Cancer Center, Madison, WI, USA.

University of Wisconsin Carbone Cancer Center, Madison, WI, USA.

出版信息

Patient Educ Couns. 2024 Jun;123:108177. doi: 10.1016/j.pec.2024.108177. Epub 2024 Feb 1.

DOI:10.1016/j.pec.2024.108177
PMID:38341898
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10997451/
Abstract

OBJECTIVE

Allogeneic hematopoietic cell transplant (alloHCT) offers many patients with blood cancers a chance of cure but carries risks. We characterized how hematologists discuss the high-risk, high-reward concept of alloHCT.

METHODS

Qualitative analysis of video-recorded virtual encounters of hematologists who routinely perform alloHCT with actors portraying an older man recently diagnosed with high-risk myelodysplastic syndrome.

RESULTS

Hematologists (n = 37) were a median age of 44 years, 65% male, and 68% white. They frequently used "teeter-totter" language that juxtaposed alloHCT's risks and rewards in a dynamic, quickly alternating fashion and communicated uncertainty in transplant outcomes. This dialogue oscillated between encouragement about alloHCT's potential for cure and caution about its risks and occurred within single speech turns and in exchanges between hematologist and patient. Fewer hematologists outlined their big-picture stance on transplant's risks and benefits early in the conversation. Meanwhile, hematologists varied in how they counseled patients to manage transplant-related uncertainty and consider treatment decision making.

CONCLUSION

Hematologists use "teeter-totter" language to express hope and concern, confidence and uncertainty, and encouragement and caution about the high-risk, high-reward nature of alloHCT.

PRACTICE IMPLICATIONS

Teeter-totter language may help frame big-picture content about alloHCT's risks and benefits that is essential for patient education and decision making.

摘要

目的

异基因造血细胞移植(alloHCT)为许多血液癌症患者提供了治愈的机会,但也存在风险。我们描述了血液科医生如何讨论 alloHCT 的高风险、高回报概念。

方法

对常规进行 alloHCT 的血液科医生与扮演近期诊断为高危骨髓增生异常综合征的老年男性的演员进行的视频记录虚拟访谈进行定性分析。

结果

血液科医生(n=37)的中位年龄为 44 岁,65%为男性,68%为白人。他们经常使用“跷跷板”语言,以动态、快速交替的方式并传达移植结果的不确定性来对比 alloHCT 的风险和回报。这种对话在 alloHCT 治愈潜力的鼓励和对其风险的警告之间来回波动,并发生在单个演讲回合内以及血液科医生和患者之间的交流中。较少的血液科医生在对话早期就概述了他们对移植风险和益处的总体立场。同时,血液科医生在指导患者管理移植相关不确定性和考虑治疗决策方面存在差异。

结论

血液科医生使用“跷跷板”语言来表达对 alloHCT 的高风险、高回报性质的希望和担忧、信心和不确定性、鼓励和警告。

实践意义

跷跷板语言可能有助于构建 alloHCT 的风险和益处的总体内容,这对于患者教育和决策至关重要。